Diabetes

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.

A recent study utilizing UK Biobank data has identified a significant rise in new-onset mental health disorders—specifically depression, anxiety, and alcohol use disorders—among adults with metabolic diseases such as hypertension, diabetes, and obesity in the aftermath of the COVID-19 pandemic.

AI safely matches senior doctors in hospital insulin dosing for T2D, easing clinical load without compromising care.

Semaglutide significantly improves liver inflammation and fibrosis in MASH patients, offering new hope for clinical management.

Low-energy diets are safe in pregnancy with gestational diabetes but show no clinical benefit in weight or birth weight.

Read about how vitamin supplementation does not significantly influence the development or progression of Type 1 diabetes.

Switching to tirzepatide yields greater HbA1c and weight reductions than escalating dulaglutide in Type 2 diabetes.

Elevated triglycerides in well-controlled gestational diabetes linked to increased pregnancy risks, suggesting lipid monitoring may be crucial.